Pharmaceutical Business review

Hi-Tech lidocaine HCl Jelly, 2% receives FDA final approval

The company claims the jelly is a generic version of APP Pharmaceuticals’ Xylocaine.

Lidocaine HCl jelly, 2% is indicated for the prevention and control of pain in procedures involving the male and female urethra, for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation.

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded prescription and OTC products.